VIP activation of rat anterior pituitary adenylate cyclase  by Robberecht, P. et al.
The brain gut octacosapeptide VPP (vasoactive 
intestinal peptide) is found in discrete areas in the 
cerebral cortex, the hypothalamus and the posterior 
pituitary gland [I A]_ Specific VIP binding sites are 
coupled to an adenylate cyclase system in synaptic 
membranes from guinea pig brain [5 $51. 
Besides, the concentration of VIP in the hypo- 
thalamo-hypophysial portal vessels is much higher 
than in the systemic blood [7]. The peptide has how- 
ever no established function in the hypophysis [7,8]. 
These data document the presence in the rat pituitaq-- 
of functional VW receptors existing in the form of a 
VIP-stimulated adenylate cyclase system and suggest 
that VIP might be a major peptidic acftivator of rat 
adenopittiitary membrane adenylate cydase. 
the neuropituitary gland whenever indicated and al! 
subsequent stegs were per.<ormed at 2-4°C. Each 
pool was homogenized separateiy in 5 ml 20 mM 
Tris-HCI hcffer bH 7-4) containing 0.25 M sucrose, 
5 mM 2mercaptoethanol,l mM EDTA and 2 mM 
MgCIZ , by :-’ up-and-down manual strokes with a 
glass-Tefloil homogenizer. The anterior pituitary 
homogenate was submitted to a 1 SO X g, 10 min 
centrifugation. The supernatant was centrifuged at 
4000 X g for 15 min and the resulting pellet was 
resuspended in the homogenizing buffer and imme- 
diately assayed for its adeny‘iate cyclase activity and 
later on for its protein content [93_ 
with free access to a standard iet and water were 
sacrificed at 09:00--l 0100 by decapitation. The 
anterior pituitary lobes were rapidly separated from 
Abb~&iatio~*~: GppQGH)p, guanosine §‘-fp;r-imido)trip~osp~ate; 
VIP, vasoractive intestinal peptick; EGTA, ethylene glycol-bis- 
(2~minoethylether)~,~~~-tetr~a~tic acid; PGE, , prosta- 
glandin E, 
* % whom correspondence should be addressed 
The incubation medium contained OS mM 
[cY-~~P]ATP, 2 mM cyclic AMP, 6 mM h4gC12 T 0.5 mM 
EGTA, 1 mM 2-mercaptoethanol, 1 mM theophyllice, 
10 mM phospho(enoI)pyruvate, 30 pglml pyruvate 
kinase and 30 n&l T~ls-HCI. The pN was adjusted tn 
7.4 at 25°C. The reaction was initiated by the addition 
of 10 ~1 crude homogenate or reho;nogenized pellet 
(IO-50 pg protein). ‘K’he total volume of the incuba- 
tion was 60 pl. Under: a!1 onditions tested, the 
enzymatic kinetics w.zre linear for at least 10 min at 
37°C. Pn routine asszqs, the reaction was stopped 
after 10 min at 37’OC by adding 05 ml OS% sodium 
dodecyklfate solutBxr containtig 1 S mM ATP, 
OS mM cyclic AMP and cyclic [8~3H]AMF 
(20 000 cpm for determination of cyclic nucleotide 
recovery). ‘khe separs.tion of cyclic AMP was achieved 
by the double column procedure [IO]. 
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SyntheiZic secretin, [VaF+xetin, [Ala4&.ecretin. 
[D-Ala4]secretin, [Glu3]secretin, [Asn3]secretin, and 
secretin(7-27) were generous gifts of Dr W. Kiinig 
(Hoecbst AkiiengesePlschaft , Frankfurt); essentially 
pure natural porcine VIP was prepared by DP V. Mutt 
(KaroPinska Institutet, Stockholm) and supplied by 
the National Institutes of He&h (Bethesda, MD); 
bombesin was synthesized by Dr R. de Castiglione 
(Farmitalia Montedison, Milano); the C-terminal octa- 
peptid.e of Fancreozymin and somatostatin were gifts 
from, respectively, Dr S. 3. Luciana (Squibb Institute 
for Medical Research, Princeton, NJ) and 
Dr R. Deghenghi (Ayerst Research Laboratories, 
Montreal, Quebec). Porcine glucagon was supplied 
by NOW Industries (Qpenhagen) and TRH, LH-IN, 
Met-enkephalin, and Leuenkephalin were purchased 
from Union Chimique Beige (Brussels). PGEr a‘nd 
PGE, were generous gifts from Drs D. A. v2n Dorp 
and D. N. Nugteren (Unilever, Vlaardingen). ATP, 
GTP, Gpp(IW)p, phospho(enol)pyruvate and pyruvate 
kinase were obtained from Sigma Chemical Co. 
(St Louis, MO). Cyclic [S-3H]tiW and [cE-~~P]~ATP 
from the Radiochemical Centre (Amersham) had a 
specific radioactivity of, respcitively, 27 Ci/mmol 
and 1-l 0 Ci/mmol_ AlI ‘others reagents were of the 
highest grade available. 
activity in pituitmy h@PaogemJtes 
orientation experiments conducted on total P-at 
pituitary homogenates allowed the detection of ap1 
adenylate cyclase activity stimulated by VW, the 
guanyl r?ucleotides CTP and Gpp(NM)p, and by 
sodium fluoride. At an optimal lW6 M concentration, 
VIP stimulated the enzyme l.8--2.0-fold (not shown). 
This VIP activation was mostI@ confined to the 
anterior portion of the gland (table I, panel A) since 
a Mold stimulaaion of bass1 adenylate cyclase actitiity 
was observed in adenohypophysis homogenates as 
compared to a 1 .$-fold stimulation only in posterior 
pituitary homogenates. Stimulations evoked by VIP 
and by G7P or Gpp(NH)p were purely additional 
(table 1, panel B]. 
The activation of adenylate cyclase by VBP in 
anterior pituitary homogenates was alieady significant 
at a low 3 X ICY9 M IUP concentration (fig.1). The 
dose-effect curve appeared bipbasic with one com- 
pdnent maximalPy stinwlated at VIP concentrations 
in the 3 X 10L8 hip range, and a second component 
maximally stimulated at high 3 X fW7 -1 X ICY6 M 
concentrations_ A similar biphasic curve of VIP- 
stimulated adenylate cyclase activity was also observed 
Table I 
Aden)~late cYclase activity in homogenates of male rat adenohypophysis and 
posterior hypophysis 
Expt Addition Adenohypophysis Posterior hypophysis 
A None 48% 6 52k 7 
lo-’ M GTP 61* 6 672 7 
1 o-s RI Gpp(NH)F 140 5 15 124 + 10 
IQ-6 M VIP 1515 15 15% 7 
10 mM NaF 382 -t 20 398 f 20 
B None 43-r 2 
1W5 M GTP 65i 5 
1 o-5 PI% 6pp(NH)p 108-t 13 
10-e M VIP 134-F 15 
1O-5 MCTP+lW6 MWB 166 T 20 
10-s M GppfrdH)p + 10-L r&4 VIP P91? 23 
BR data are expressed as pm01 cyclic AMP formed .rni91-~ mg protein-“. Means f SEA% 
of 4 (A) and 6 (Bj expt performed in duplicate under standard conditions as detailed in 
section 2 
Fig.1. Do&response curves of adenylate cydase activity 
stimulated by natural ‘VIP (e--m), synthetic secretin 
(a-0) and synthetic [VaF]:; ecretin (o-o) in adeno- 
pituitary homogenates from nzale rats. IBe dose-effect curve 
for ViP is the mean 2 SEM of 6 expt perf;lrmed in duplicate. 
The secretin and [%Ps]secretin dose-effect curves are the 
means of 3 expt. Resuults are expressed in pm01 cyclic AMP 
formed min-” _rng protein-’ in excess of the basal 
unstirnulated v&t. The mean basal activities were 41 5 2 and 
43 pmol _min-’ .mg protein-’ for, respectively,.the first 
and the two last dose-effect cmves. 
in membrane preparations (fig.3 and vide infra). This 
might suggest he existence of two functionally distinct 
classes of VIP receptors having, respectively, high 
affinity-low capacity and low affinity-high capacity- 
Conceivably, these distinct classes of VIP receptors 
might originate from the same or from different cell 
types. 
Among the parent peptides tested (including 
secretin, ghcagon, [Vals]secretin, [Glu3)secretin. 
[Asn3]secretin, [Ak?]secretin, [D-Ma4]secretin and 
the secretin fragment (7-271, only two were found 
to be weak activators of the adenopituitary adenylate 
cyclase. Secreltin was efficient only at a very high 
3 X PO-~ lU concentration. [Val’]secretin with the 
Thr’ residue in secretin replaced by Va15 (the amino 
acid iesidue present in the same position in VIP) 
proved to be more efficient than secretin at 
3 X 1 Cl-’ M but yert 1 MI-fold less potent than VIP. 
Th$s peptide has ehe same relatively high potency on 
the adenylate cyclase activity of guinea pig brain 
membranes (P.R. et al., unpublished data). 
A series of neuropeptides normally present in the 
hypothalamus, including TECH, LH-RH, Met- and 
Leuenkephalin, somatostatin, bombesin and the 
C-terminal octapeptide of pancreozymin were unable 
to affect adenylate cyclase activity when offered at 
1 X iO_* -3 X 1 0L5 M and in the absence as well as 
in the presence of VIP (data not showy). This was 
perhaps surprising considering that hypothalamic 
factors such as TM, LWW and the ill-defined GH- 
iRH factor are supposed to a& on anterior pituitary 
cells by increasing intracelluk cyclic AMP levels. 
The published evidence in fasTor of this uncertain role 
of cyclic AMP inciudes: 
1 _ Increases in cyclic AMP levels in pituitary glands 
incubated in. the presence of the peptide factors 
and of a phosphodiesterase inhibitor; 
2. Stimulation of secretion and synthesis of pituitary 
hormones by dibutyryl cyclic AMP Ii I ,I 21. 
This view has been challenged, however, since a 
direct activation of p3tuitary adenylate cyclase by 
TRH and EH-RN could not be demonstrated in crude 
extracts as well as in pure plasma membranes, even 
when a guanyi nucle.>tide was added [13,14]. 
At variance ;with these ncgativz results,we observed 
a stimulation of adenylate cyciase activity wjth WEI 
(not shown) and wiih PGE2 $g.2). This stimulation 
and that of VIP proved to be additive (fig.2). Prosia- 
glandins EI aiid E2 are known to stimulate the release 
of rat anterior pituitary hormones including RCTH 
[ 153, growth hormone 13 61 and prolactin [I 2-I 61 
and to activate rat anterior pituitary adenylate cyda~ 
[I 71. The purely additive effects of VP and prosts- 
glandins on adenyBate cyck se activation suggest he 
independence of both stirrulations. It remair?s to be 
established whether both agents acted upon plasma 
membranes from dis-ii;tct cell types or OR independent 
catalytic subunits ri-om the same ceU membranes. 
Further experiments were conducted on 1% X 8 
to 4000 X g sedime.xts. The effects of VIP, secretin 
analogs, neuropeptides and prostaglandins were 
basically identical to those exerted ofi totaI homog- 
enates, with only one major difference Cfig.3). GTE’ 
and Gpp(NH)p, at concentrations giving maximal 
intrinsic activity, increased Z-fold the amc;;nt of 
cyclic AMBZ produced in the presence of W? alone. 
This clear potentiation of VIP by both guany! 
nucleotides makes the VP-sensitive adenylate cydase 
system of adenopituitary particulate fraction com- 
parable to that of mouse liver 1181 and rat pancreas 
[13]. This might result from the elimination cf labi&: 
‘Jolume 103, number 2 
LOG VIP or PCE2 COMCENTRAflON (LOG M 1 
Fig.2. Dose--response curves of adenylate cydase activity 
stimulated by RX, (o-02, VP (n-a) or by VIP in the 
presence of I W5 M PGE, (a-A) in adenopituitary 
homogenates from male rats. The results are the mean of 3 
expt and are expressed in pm01 Cyclic AMP formed Snin-’ 
9ylg protek -I in excess of the basal unstimulated value. The 
mean basal activity was 50 prIlOl CYCliC AMP .B;ahn-” .mg 
protein_’ . 
endogenous guanyl nucleotides and/or protein factors 
acting like GTP [‘Xl] that were responsible hr the 
relatively high basa1 activity of adenylate cyclase as 
well as for the lack of pot.entiation of VIP by 
exogenous GTP or Gpp@JH)p in a crude homogenate 
(see table 1). 
As in adenopituitary homogenate, the stimuPatory 
effects of prostqlandins E, zind E, and those of VHP 
were additive in the adenopituitary particulate frac- 
Con. Bn the latter case, the presence of GTP was 
required for adenylate cyclase activation by the 
prostaglandins (data mot dmvn). 
The biologicd significance of the present data 
might be ofimportance. Up to now, VIP was reported 
[8] to cause a dose-related increase fn plasma peolactin 
when injected into the rd ventride or intrawenously 
Po rats. This effect was suppressed by nalloxone and by 
L-dopa and could not be reproduced in vim on 
232 
VIP 
LOG VIP CONCENTi?~TlON ;L()G M ) 
Fig.3. Dose-response curves of adenyfate cyclase activi’ry 
stimulated by natural VIP, in the absence (e----o) or in the 
presence of 1 0e5 %I GTP (o--A) or 40m5 M Gpp(NH)p 
(A- -A) in an a&nOpituitary patiic@ate fraction. This 
fraction was the resuspended 4000 x g pellet obtained 
after centrifugation of the II 80 X g supernatant of an adeno- 
pituitary homogenate from male r3ts. The dose-effect curves 
were the means of 4 expt performed in duplicate. The results 
were expressed in pmol cyclic AMP formed .min-* .mg 
protein-l in excess of the corresponding control values, i.e., 
33,74 and 172 pmoP cyclic AMP min-’ _mg protein-” 
formed, respectively, in the absence of any addition, and in 
the presence of 1 O-’ M GT’P or 1 O-’ M Gpp(NH)p_ The 
values found in the presence of nucleotides were significantly 
higher than those observed in the absence of nucleotides 
@ < 0.001 based on Student’s t test for paired values). 
cultured pituitary cek. Similar in vivo and in vitro 
effects on the release of growth hormone 2s ere 
observed [7]. These data suggest that 
act on kmn~ne secreting cells of the adeno- 
hypophysis through opiate receptors. me present 
demonstration of VP receptors coupled to a& 
adenylate cyclase indicates as an added mechanism 
the direct involvement of VIP in adenopituitary 
adenylate cydase iystem(sj. This biological event 
might be related to the stimulation of prolactin 
release by VP recently demonstrated im incubated 
anterior pituitaries from male rats [21]. 
Aided by grant 20,403 from the Fends de la 
Recherche $c~e~ti~~~e MCdicale, Belgium and grant 
RO-1AM-B70~0 from the National Hnstitutes of 
Health) USA. 
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